CJC-1295 Without DAC Research Overview

CJC-1295 Without DAC is a synthetic 29-amino-acid analog of growth hormone-releasing hormone (GHRH 1-29), designed for preclinical and in vitro research. This variant lacks the Drug Affinity Complex (DAC), resulting in a shorter systemic half-life relative to DAC-modified CJC-1295. Researchers utilize this peptide primarily for studying GHRH receptor signaling, cAMP/PKA-mediated intracellular pathways, and GH-axis dynamics in laboratory models.

The peptide is of interest in the scientific literature for investigations into GH secretion modulation, endocrine signaling, and comparative pharmacokinetics between short- and long-acting GHRH analogs. Peer-reviewed mechanistic studies are limited; most information derives from research supplier technical documentation and preclinical assay reports.

Mechanism of Action in Laboratory Models

CJC-1295 Without DAC has been explored in preclinical research for its selective GHRH receptor agonism:

• GHRH Receptor (GHRH-R) Activation

  • Laboratory studies investigate receptor binding and downstream cAMP/PKA signaling in pituitary somatotroph models.

  • Used to model transient GH release patterns in vitro and in rodent systems.

• Short Half-Life vs. DAC-Modified Analogs

  • The absence of DAC allows for rapid clearance in experimental models, supporting investigation of pulsatile vs. prolonged GH release.

• Single-Target Activity

  • Mechanistic studies focus on GHRH-R without documented pleiotropic receptor interactions.

Primary Research Findings

Research on CJC-1295 Without DAC is primarily preclinical and mechanistic:

• GH Secretion Dynamics

  • Laboratory studies demonstrate short-term increases in GH release consistent with GHRH-R activation.

• Comparative Studies

  • Used alongside DAC-modified analogs to investigate half-life-dependent differences in GH signaling and pharmacokinetics in vitro.

• Metabolic Research Applications

  • Experimental models assess GH-related modulation of cellular markers in hepatocytes, adipocytes, or other tissues, without clinical outcome implications.

Note: Literature is limited and largely derived from supplier technical sheets or preclinical assay reports; peer-reviewed publications are scarce.

Research Applications

Endocrine and GH-Axis Research

• Investigates GHRH receptor signaling, intracellular cAMP/PKA activity, and transient GH release patterns.

• Experimental endpoints include GH quantification, receptor activation assays, and downstream pathway measurements.

Metabolic Signaling Research

• Explored in cellular models of GH-responsive tissues, such as hepatocytes or adipocytes, to assess GH-associated intracellular responses.

• Provides a controlled model for short-acting GH-axis modulation.

Comparative Peptide Investigations

• Applied alongside DAC-modified CJC-1295 to study pharmacokinetic and mechanistic differences.

• Supports experimental design for short- versus long-acting GHRH analog studies.

Research Handling and Format

• Lyophilized Powder: Freeze-dried to maintain peptide stability and reproducibility.

• Storage: Store in a cool, dry, light-protected environment.

• Reconstitution: Short-term stability post-reconstitution is typical; lab-specific conditions may affect usability.

• Research Use Only: Intended solely for preclinical and in vitro research; not for human consumption or clinical use.

Peptide Identity and Molecular Profile

References

• Literature on CJC-1295 Without DAC is primarily preclinical and derived from peptide supplier specifications.

• Verified references on GHRH receptor signaling and short-acting analogs:

  • Ho, K. Y., & Veldhuis, J. D. (1995). Mechanisms controlling pulsatile GH secretion in laboratory models. Endocrine Reviews, 16(6), 725–757.

  • Peptide supplier technical datasheets (various sources) provide sequence, molecular weight, and handling information.

Note: Peer-reviewed mechanistic studies specifically for CJC-1295 Without DAC are limited; most data originate from preclinical assay reports and manufacturer documentation.